Horizon Therapeutics Public Ltd Co

GUGGENHEIM CAPITAL LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

37,033

Value ($000)

4,284

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	4,284	0.0%	37,033	9/30/2023
2023 Q2	8/11/2023	5,972	0.0%	58,069	6/30/2023
2023 Q1	5/11/2023	7,479	0.1%	68,527	3/31/2023
2022 Q4	2/14/2023	8,972	0.1%	78,844	12/31/2022
2022 Q3	11/14/2022	5,572	0.1%	90,025	9/30/2022
2022 Q2	8/15/2022	6,875	0.1%	86,192	6/30/2022
2022 Q1	5/16/2022	7,637	0.0%	72,590	3/31/2022
2021 Q4	2/14/2022	9,541	0.1%	88,535	12/31/2021
2021 Q3	11/15/2021	11,140	0.1%	101,694	9/30/2021
2021 Q2	8/13/2021	8,213	0.0%	87,713	6/30/2021
2021 Q1	5/13/2021	8,064	0.1%	87,610	3/31/2021
2020 Q4	2/16/2021	6,614	0.0%	90,414	12/31/2020
2020 Q3	11/13/2020	6,677	0.0%	85,948	9/30/2020
2020 Q2	8/14/2020	6,630	0.1%	119,274	6/30/2020
2020 Q1	6/2/2020	341	0.0%	11,515	3/31/2020
2019 Q4	2/20/2020	306	0.0%	8,465	12/31/2019